comparemela.com
2
3
4
5
6
7
8
Latest Breaking News On - Domain antibodies - Page 1 : comparemela.com
Tisotumab Vedotin Marketing Authorization Application Validated by European Medicines Agency for Treatment of Recurrent or Metastatic Cervical Cancer | Antibodies
Tisotumab Vedotin Marketing Authorization Application Validated by European Medicines Agency for Treatment of Recurrent or Metastatic Cervical Cancer
Copenhagen
Køavn
Denmark
New-jersey
United-states
Japan
Netherlands
Tokyo
Roger-dansey
Tisotumab-vedotin
Pfizer-inc
Drug-administration
Sandoz announces agreement to acquire CIMERLI® business from Coherus, strengthening position in US market | Antibodies
Sandoz announces agreement to acquire CIMERLI® business from Coherus, strengthening position in US market
United-states
American
Coherus-biosciences
Choroidal-neovascularization
Keren-haruvi
Coherus-biosciences-inc
Genentech-united-states-inc
American-academy-of-ophthalmology
Switzerlandi-january
President-sandoz-north-america
Age-related-macular-degeneration
Edema-following-retinal-vein-occlusion
Imfinzi plus bevacizumab met primary endpoint for progression-free survival in liver cancer eligible for embolisation in EMERALD-1 Phase III trial | Antibodies
Imfinzi plus bevacizumab met primary endpoint for progression-free survival in liver cancer eligible for embolisation in EMERALD-1 Phase III trial
China
London
City-of
United-kingdom
Canada
Kunlun
Zhejiang
South-korea
Cambridge
Cambridgeshire
Italy
Sweden
Qilu Pharmaceutical to Showcase Novel Anti-Cancer Drug QL1706 at ESMO Congress 2023 | Antibodies
Qilu Pharmaceutical to Showcase Novel Anti-Cancer Drug QL1706 at ESMO Congress 2023
Qilu
Gansu
China
Madrid
Spain
Jinan
Shandong
European-society-for-medical-oncology
Qilu-pharmaceutical
Showcase-novel-anti-cancer-drug
Chinai-october
LabGenius & Sanofi partnership yields positive results from AI antibody discovery platform
Today, LabGenius, a pioneer in the use of AI and machine learning for antibody discovery, releases new data from its antibody discovery platform following a multi-year collaboration with Sanofi.
Paris
France-general
France
From-labgeniussep
Big-pharma
Domain-antibodies
Antibody
Antibody-discovery
Machine-learning
Technology
vimarsana © 2020. All Rights Reserved.